University of British Columbia
Pieter Cullis pioneered lipid nanoparticle delivery systems that enable mRNA vaccines and RNA therapeutics. His decades of work on lipid biophysics made possible the delivery technology behind COVID-19 mRNA vaccines and several approved gene-silencing drugs.
H-INDEX
100
PUBLICATIONS
380
FIELD
Biochemistry
100
H-INDEX
380
PUBLICATIONS
40
GRANTS
70
PATENTS
INDUSTRY TIES
Acuitas Therapeutics
Precision NanoSystems
Genevant Sciences
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED